Lil’ Drug Store
This article was originally published in The Rose Sheet
Executive Summary
Firm refers wholesalers and retailers to its Convenience Profitability Program, a health and beauty-care (HBC) category management initiative to increase sales of convenience-sized health and beauty items, according to Oct. 15 release. "Currently, HBC is underdeveloped and represents only a small percentage of in-store sales. ... The section is highly SKU-intensive, has many subcategories and a history of complicated [legislation]. These challenges are worth reviewing though, as [HBC] items contribute high margins," release notes. Program promises to make the HBC section of a store easy to run by providing account-specific plan-o-gram development and customer-specific sales tools, among other services. "Wholesalers and retailers that have implemented the convenience profitability program have increased distribution of top-moving products and reduced the total number of SKUs carried by up to 50 percent," Paul Rossberger, VP-sales and marketing for Lil' Drug Store Products, says...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.